首页> 外文期刊>Journal of the American Chemical Society >Glycomimetic Ligands for the Human Asialoglycoprotein Receptor
【24h】

Glycomimetic Ligands for the Human Asialoglycoprotein Receptor

机译:人体拟糖基糖蛋白受体的拟糖配体

获取原文
获取原文并翻译 | 示例
           

摘要

The asialoglycoprotein receptor (ASGPR) is a high-capacity galactose-binding receptor expressed on hepatocytes that binds its native substrates with low affinity. More potent ligands are of interest for hepatic delivery of therapeutic agents. We report several classes of galactosyl analogues with varied substitution at the anomeric, C2-, C5-, and C6-positions. Significant increases in binding affinity were noted for several trifluoromethyl-acetamide derivatives without covalent attachment to the protein. A variety of new ligands were obtained with affinity for ASGPR as good as or better than that of the parent JV-acetylgalactosamine, showing that modification on either side of the key C3,C4-diol moiety is well tolerated, consistent with previous models of a shallow binding pocket. The galactosyl pyranose motif therefore offers many opportunities for the attachment of other functional units or payloads while retaining low-micro-molar or better affinity for the ASGPR
机译:去唾液酸糖蛋白受体(ASGPR)是在肝细胞上表达的高容量半乳糖结合受体,它以低亲和力结合其天然底物。更有效的配体对于肝递送治疗剂是令人感兴趣的。我们报告了几类半乳糖基类似物,在异头物,C2-,C5-和C6-位置具有不同的取代基。注意到对几种三氟甲基-乙酰胺衍生物的结合亲和力显着增加,而没有共价附于蛋白质。获得了许多对ASGPR的亲和力优于或优于亲本JV-乙酰半乳糖胺的新配体,表明对关键C3,C4-二醇部分任一侧的修饰均具有良好的耐受性,这与以前的ASGPR模型相符。浅装订袋。因此,半乳糖基吡喃糖基序为连接其他功能单元或有效载荷提供了许多机会,同时保留了对ASPGR的低微摩尔或更好的亲和力

著录项

  • 来源
    《Journal of the American Chemical Society》 |2012年第4期|p.1978-1981|共4页
  • 作者单位

    Department of Chemistry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, United States,These authors contributed equally;

    Department of Chemistry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, United States,These authors contributed equally;

    Pfizer Global Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States;

    Pfizer Global Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States;

    Pfizer Global Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States;

    Pfizer Global Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States;

    Pfizer Global Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States;

    Pfizer Global Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States;

    Pfizer Global Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States;

    Pfizer Global Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States;

    Pfizer Global Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States;

    Pfizer Global Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States;

    Pfizer Global Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States;

    Pfizer Global Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States;

    Pfizer Global Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States;

    Department of Chemistry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, United States;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号